Dr. Dennis R. Beatty, MD

Dr. Beatty practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Beatty's NPI, 1427074699, was assigned on July 14, 2006. Dr. Beatty graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 1994. Dr. Beatty holds Vermont license 042-0010372.

Dr. Beatty's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Beatty's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Beatty is also affiliated with Central Vermont Medical Center. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Beatty to 2 more hospitals, 2 home health agencies, 1 dialysis center, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beatty practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Beatty's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Beatty is licensed in Vermont.

CMS data shows 659 Medicare services from Dr. Beatty across 7 procedure codes in 2024, for 371 Medicare patients. Medicare paid $42,093 for them. Every service was in an office.

CMS counts 371 Medicare patients who saw Dr. Beatty in 2024. The largest group is 65 to 74, with 195 patients. 66% of them have high blood pressure, and 63% have high cholesterol. 8% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Beatty's median patient age at 71, with 44% women.

In 2024, Dr. Beatty wrote 6,582 Medicare Part D claims for 677 patients. 88% of them were for generic drugs. CMS names the drug for 5,795 of them, across 123 drugs with 11 or more claims each, at $524,041 in total drug cost. In 2023, CMS named 5,017 claims across 111 drugs.

Dr. Beatty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beatty as offering telehealth. CMS counts 12 procedures of removal or shaving of skin growth by Dr. Beatty, more than 65% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Beatty. Dr. Beatty's most frequent co-author is Tania Fernandez Bertsch, MD.

CMS Open Payments shows 1 general payment to Dr. Beatty from 1 drug or device company in 2018. Speaker and faculty fees make up the largest share, 100% of the total. Indivior Inc. paid the most, $125.

Dr. Beatty graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 1994.